Search Results

The Avanos* CORTRAK* 2 Enteral Access System (EAS) utilizes tube tracking technology to assist, in conjunction with institution protocols, qualified clinicians in guiding the placement of Avanos Medical CORTRAK* 2 feeding tubes of 8FR or greater into the stomach or small bowel of patients requiring enteral feeding.

The Avanos* CORTRAK* 2 Enteral Access System (EAS) utilizes tube tracking technology to assist, in conjunction with institution protocols, qualified clinicians in guiding the placement of Avanos Medical CORTRAK* 2 feeding tubes of 8FR or greater into the stomach or small bowel of patients requiring enteral feeding.

The provided text is a letter from the FDA regarding the 510(k) premarket notification for the CORTRAK* 2 Enteral Access System. This letter determines substantial equivalence but does not contain the detailed acceptance criteria and study information requested. It primarily focuses on regulatory compliance, general controls, and classification of the device.

Therefore, I cannot extract the specific information about:

• A table of acceptance criteria and reported device performance
• Sample size used for the test set and data provenance
• Number of experts used to establish ground truth for the test set and their qualifications
• Adjudication method for the test set
• Multi-reader multi-case (MRMC) comparative effectiveness study results or effect size
• Standalone algorithm performance
• Type of ground truth used
• Sample size for the training set
• How ground truth for the training set was established

This type of information would typically be found in the 510(k) summary document or the full submission, which is not provided here.

Ask a specific question about this device